[go: up one dir, main page]

CN106083728A - Diaryl the synthetic method of Diazepines - Google Patents

Diaryl the synthetic method of Diazepines Download PDF

Info

Publication number
CN106083728A
CN106083728A CN201610381171.2A CN201610381171A CN106083728A CN 106083728 A CN106083728 A CN 106083728A CN 201610381171 A CN201610381171 A CN 201610381171A CN 106083728 A CN106083728 A CN 106083728A
Authority
CN
China
Prior art keywords
diaryl
reaction
diazepines
synthetic method
follows
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201610381171.2A
Other languages
Chinese (zh)
Other versions
CN106083728B (en
Inventor
李红梅
徐晨
王志强
娄新华
付维军
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Luoyang Normal University
Original Assignee
Luoyang Normal University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luoyang Normal University filed Critical Luoyang Normal University
Priority to CN201610381171.2A priority Critical patent/CN106083728B/en
Publication of CN106083728A publication Critical patent/CN106083728A/en
Application granted granted Critical
Publication of CN106083728B publication Critical patent/CN106083728B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

本发明涉及一种二芳基并二氮杂卓类化合物的合成方法,具体为:取邻卤代芳基甲醇、1,2‑二胺芳烃、钌催化剂、铜盐、乙二醇、和碱加入到有机溶剂中,在N2保护下加热,反应结束后萃取、蒸干、重结晶即得产物;本发明利用商品可得、价格较低的钌、铜催化剂共催化邻卤代芳基甲醇和1,2‑二胺芳烃的反应,通过氢转移反应和碳氮偶联反应一步生成二芳基并二氮杂卓类化合物,该合成方法操作简单、经济高效、产率高,具有重要的应用价值。The present invention relates to a kind of synthetic method of diaryl diazepine compound, specifically: take o-halogenated aryl carbinol, 1,2-diamine arene, ruthenium catalyst, copper salt, ethylene glycol, and alkali Add it into an organic solvent, heat it under the protection of N2 , extract, evaporate to dryness, and recrystallize to obtain the product after the reaction is completed; the present invention utilizes commercially available and relatively low-priced ruthenium and copper catalysts to co-catalyze the o-halogenated arylmethanol The reaction with 1,2-diamine aromatics generates diaryldiazepines in one step through hydrogen transfer reaction and carbon-nitrogen coupling reaction. This synthesis method is simple, economical and efficient, and has high yield. It has important Value.

Description

二芳基并二氮杂卓类化合物的合成方法Synthetic method of diaryl diazepines

技术领域technical field

本发明涉及有机合成技术领域,具体涉及二芳基并二氮杂卓类化合物的合成方法。The invention relates to the technical field of organic synthesis, in particular to a synthesis method of diaryldiazepine compounds.

背景技术Background technique

二芳基并二氮杂卓类化合物一类具有重要生理活性和药理活性的化合物,常用作抗抑郁剂、抗惊厥、镇静、镇痛等方面的药物。该类化合物还具有抗真菌、抗细菌、抗病毒等作用,因此对其合成方法的研究一直得到人们的广泛关注。传统的合成方法以邻卤芳胺、邻硝基芳胺或邻氨基苯甲酸为起始原料,通过多步反应来合成,这些方法需要使用毒性很大的试剂,反应条件苛刻,总产率较低,对环境污染大。近年来,以过渡金属催化的偶联反应已成为有机合成的重要手段,是目前研究最多和最有前途的一种方法。其中钯催化卤代芳烃碳氮键偶联的反应已有很多报道,但钯催化剂较为昂贵,限制了其在工业上的一些应用。Diaryldiazepines, a class of compounds with important physiological and pharmacological activities, are often used as antidepressants, anticonvulsants, sedatives, analgesics and other drugs. This kind of compound also has antifungal, antibacterial, antiviral and other effects, so the research on its synthesis method has been widely concerned by people. Traditional synthetic methods use o-haloarylamine, o-nitroarylamine or anthranilic acid as starting materials and synthesize them through multi-step reactions. These methods require the use of very toxic reagents, harsh reaction conditions, and low overall yields. Low, great environmental pollution. In recent years, coupling reactions catalyzed by transition metals have become an important means of organic synthesis, and are currently the most studied and most promising method. Among them, palladium-catalyzed carbon-nitrogen bond coupling reaction of halogenated aromatic hydrocarbons has been reported a lot, but the palladium catalyst is relatively expensive, which limits its industrial application.

发明内容Contents of the invention

本发明的目的是为解决上述技术问题的不足,提供一种二芳基并二氮杂卓类化合物的合成方法。The object of the present invention is to provide a kind of synthetic method of diaryl diazepine compound in order to solve the deficiency of above-mentioned technical problem.

本发明为解决上述技术问题的不足,所采用的技术方案是:一种二芳基并二氮杂卓类化合物的合成方法,具体为:取邻卤代芳基甲醇、1,2-二胺芳烃、钌催化剂、铜盐、乙二醇和碱加入到有机溶剂中,在N2保护下加热,反应结束后萃取、蒸干、重结晶即得产物;In order to solve the deficiencies of the above-mentioned technical problems, the technical solution adopted by the present invention is: a synthesis method of diaryldiazepine compounds, specifically: taking o-halogenated arylmethanol, 1,2-diamine Aromatic hydrocarbons, ruthenium catalysts, copper salts, ethylene glycol and alkalis are added to organic solvents, heated under the protection of N2 , after the reaction is completed, extraction, evaporation to dryness and recrystallization are carried out to obtain the product;

二芳基并二氮杂卓类化合物的制备方法如下:The preparation method of diaryl diazepines is as follows:

;

所述邻卤代芳基甲醇的结构式如下所示:The structural formula of the o-halogenated aryl carbinol is as follows:

;

所述1,2-二胺芳烃的结构式如下所示:The structural formula of the 1,2-diamine arene is as follows:

;

其中:R为-H、-CH3、-OCH3、-F或-CF3,R位于芳环1-4上任一位置;X为-Br或-I; R1可以是-H或-CH3;R2为-H、-CH3、-OCH3、-COOMe、-CN、-F或-CF3,R2位于芳环5-8上任一位置;Where: R is -H, -CH 3 , -OCH 3 , -F or -CF 3 , R is located at any position on the aromatic ring 1-4; X is -Br or -I; R 1 can be -H or -CH 3 ; R 2 is -H, -CH 3 , -OCH 3 , -COOMe, -CN, -F or -CF 3 , R 2 is located at any position on the aromatic ring 5-8;

所述二芳基并二氮杂卓类化合物的结构式如下所示:The structural formula of the diaryl diazepines is as follows:

;

该二芳基并二氮杂卓类化合物中的R、R1和R2基团与邻卤代芳基甲醇、1,2-二胺芳烃的R、R1和R2基团涵义相同。The R, R 1 and R 2 groups in the diaryldiazepine compound have the same meanings as the R, R 1 and R 2 groups of o-halogenated aryl carbinol and 1,2-diamine arene.

上述二芳基并二氮杂卓类化合物的合成方法中,所述邻卤代芳基甲醇,1,2-二胺芳烃,钌催化剂、铜盐、乙二醇、和碱的摩尔比为1:1~1.5:0.03~0.1:0.05~0.1:2~6:3~9。In the synthetic method of above-mentioned diaryl diazepine compound, the molar ratio of described o-halogenated aryl carbinol, 1,2-diamine arene, ruthenium catalyst, copper salt, ethylene glycol and alkali is 1 : 1~1.5: 0.03~0.1: 0.05~0.1: 2~6: 3~9.

上述二芳基并二氮杂卓类化合物的合成方法中,所述加热反应的条件为:反应温度为80-120℃,反应时间6-48h,反应结束后用重结晶对产物进行提纯。In the synthesis method of the above-mentioned diaryldiazepine compounds, the heating reaction conditions are as follows: the reaction temperature is 80-120° C., the reaction time is 6-48 hours, and the product is purified by recrystallization after the reaction.

上述二芳基并二氮杂卓类化合物的合成方法中,所述的钌催化剂是对伞花烃二氯化钌二聚体、RuH2(PPh3)4或Ru (PPh3)2Cl2In the above synthesis method of diaryldiazepines, the ruthenium catalyst is p-cymene dichloride ruthenium dimer, RuH 2 (PPh 3 ) 4 or Ru (PPh 3 ) 2 Cl 2 .

上述二芳基并二氮杂卓类化合物的合成方法中,所述的铜盐为碘化亚铜或氯化亚铜。In the above synthesis method of diaryldiazepines, the copper salt is cuprous iodide or cuprous chloride.

上述二芳基并二氮杂卓类化合物的合成方法中,所述的铜盐为碘化亚铜或氯化亚铜。In the above synthesis method of diaryldiazepines, the copper salt is cuprous iodide or cuprous chloride.

上述二芳基并二氮杂卓类化合物的合成方法中,所述的铜盐为碘化亚铜或氯化亚铜。In the above synthesis method of diaryldiazepines, the copper salt is cuprous iodide or cuprous chloride.

有益效果Beneficial effect

本发明利用商品可得、价格较低的钌、铜催化剂共催化邻卤代芳基甲醇和1,2-二胺芳烃的反应,通过氢转移反应和碳氮偶联反应一步生成二芳基并二氮杂卓类化合物,为合成具有生物活性的取代二芳基并二氮杂卓类衍生物提供了一个实用的方法。该方法操作简单、经济高效、产率高,具有重要的应用价值。The present invention utilizes commercially available and relatively low-priced ruthenium and copper catalysts to co-catalyze the reaction of ortho-halogenated aryl carbinol and 1,2-diamine aromatic hydrocarbons, and generates diaryl groups in one step through hydrogen transfer reaction and carbon-nitrogen coupling reaction The diazepine compounds provide a practical method for the synthesis of biologically active substituted diaryldiazepine derivatives. The method is simple to operate, economical and efficient, high in yield, and has important application value.

具体实施方式detailed description

本发明的的合成方法可以制备下表所示的联二芳基并氮杂卓-5-酮类化合物:The synthetic method of the present invention can prepare the biaryl azepin-5-ketone compound shown in the following table:

以下是本发明合成发明的具体实施例,上表中的阿拉伯数字代表每种化合物的标号,实施例中的化合物标号与上表中的化合物标号一致。The following are specific examples of the synthesis invention of the present invention. The Arabic numerals in the above table represent the labels of each compound, and the compound labels in the examples are consistent with the compound labels in the above table.

实施例1Example 1

二芳基并二氮杂卓类化合物(1)的制备:在氮气保护下,向10 ml的Schlek反应管(无水无氧操作时常用的一种玻璃仪器)加入1.0mmol邻碘苯甲醇、1.0mmol 1,2-邻苯二胺、0.03mmol Ru (PPh3)2Cl2、0.03mmol碘化亚铜、2.0mmol乙二醇、2.0mmol氢氧化钠、和5ml甲苯,用氮气置换反应管3次,然后在磁力搅拌下用油浴加热至80℃,反应回流6小时。去掉油浴,水浴降到室温;向反应液加3ml水,用5ml的乙酸乙酯萃取三次,合并有机相并用无水MgSO4干燥30分钟,过滤;滤液用旋转蒸发器浓缩,浓缩后的固体以二氯甲烷为溶剂,重结晶得到纯产品1,产率80%。该产品的核磁分析数据如下:1H NMR. (400 MHz, DMSO-d6): 8.13 (s, 1H), 7.07 (t, 1H), 6.99 (d, 1H), 6.89 (m, 2H), 6.71 (d, 1H), 6.64(m, 2H), 6.55 (t, 1H), 4.11 (s, 2H)。Preparation of diaryldiazepine compounds (1): Add 1.0mmol o-iodobenzyl alcohol, 1.0 mmol 1,2-o-phenylenediamine, 0.03 mmol Ru (PPh 3 ) 2 Cl 2 , 0.03 mmol cuprous iodide, 2.0 mmol ethylene glycol, 2.0 mmol sodium hydroxide, and 5 ml toluene, replace the reaction tube with nitrogen 3 times, and then heated to 80° C. with an oil bath under magnetic stirring, and the reaction was refluxed for 6 hours. Remove the oil bath, and the water bath is lowered to room temperature; add 3ml of water to the reaction solution, extract three times with 5ml of ethyl acetate, combine the organic phases and use anhydrous MgSO Dry for 30 minutes, filter; the filtrate is concentrated with a rotary evaporator, and the concentrated solid Using dichloromethane as solvent, the pure product 1 was obtained by recrystallization with a yield of 80%. The nuclear magnetic analysis data of this product are as follows: 1 H NMR. (400 MHz, DMSO-d6): 8.13 (s, 1H), 7.07 (t, 1H), 6.99 (d, 1H), 6.89 (m, 2H), 6.71 (d, 1H), 6.64(m, 2H), 6.55 (t, 1H), 4.11 (s, 2H).

实施例2Example 2

二芳基并二氮杂卓类化合物(3)的制备:在氮气保护下,向10 ml的Schlek反应管(无水无氧操作时常用的一种玻璃仪器)加入1.0mmol邻溴苯甲醇、1.5mmol 3-甲基-1,2-邻苯二胺、0.05mmol 对伞花烃二氯化钌二聚体、0.1mmol氯化亚铜、6.0mmol乙二醇、9.0mmol氢氧化钾、和5ml二氧六环,用氮气置换反应管3次,然后在磁力搅拌下用油浴加热至120℃,反应回流48小时。去掉油浴,水浴降到室温;向反应液加3ml水,用5ml的乙酸乙酯萃取三次,合并有机相并用无水MgSO4干燥30分钟,过滤;滤液用旋转蒸发器浓缩,浓缩后的固体以二氯甲烷为溶剂,重结晶得到纯产品3,产率80%。该产品的核磁分析数据如下:1H NMR. (400 MHz,DMSO-d6): 7.12 (t, 1H), 7.01 (d, 1H), 6.70-6.76 (m, 2H), 6.51-6.61 (m,3H), 5.89 (s, 1H), 5.84 (s, 1H), 4.26 (s, 2H), 2.20 (s, 3H)。Preparation of diaryldiazepine compounds (3): Add 1.0mmol o-bromobenzyl alcohol, 1.5 mmol 3-methyl-1,2-o-phenylenediamine, 0.05 mmol p-cymene dichloride ruthenium dimer, 0.1 mmol cuprous chloride, 6.0 mmol ethylene glycol, 9.0 mmol potassium hydroxide, and 5ml of dioxane was used to replace the reaction tube with nitrogen for 3 times, and then heated to 120° C. in an oil bath under magnetic stirring, and the reaction was refluxed for 48 hours. Remove the oil bath, and the water bath is lowered to room temperature; add 3ml of water to the reaction solution, extract three times with 5ml of ethyl acetate, combine the organic phases and use anhydrous MgSO Dry for 30 minutes, filter; the filtrate is concentrated with a rotary evaporator, and the concentrated solid The pure product 3 was obtained by recrystallization with dichloromethane as solvent, and the yield was 80%. The nuclear magnetic analysis data of this product are as follows: 1 H NMR. (400 MHz,DMSO-d6): 7.12 (t, 1H), 7.01 (d, 1H), 6.70-6.76 (m, 2H), 6.51-6.61 (m,3H), 5.89 (s, 1H), 5.84 (s, 1H), 4.26 (s, 2H), 2.20 (s, 3H).

实施例3Example 3

二芳基并二氮杂卓类化合物(6)的制备:在氮气保护下,向10 ml的Schlek反应管(无水无氧操作时常用的一种玻璃仪器)加入1.0mmol邻溴苯甲醇、1.2mmol 4-甲氧基-1,2-邻苯二胺、0.04mmol RuH2(PPh3)4、0.06mmol氯化亚铜、3.0mmol乙二醇、5.0mmol叔丁醇钾、和5ml二甲苯,用氮气置换反应管3次,然后在磁力搅拌下用油浴加热至120℃,反应回流24小时。去掉油浴,水浴降到室温;向反应液加3ml水,用5ml的乙酸乙酯萃取三次,合并有机相并用无水MgSO4干燥30分钟,过滤;滤液用旋转蒸发器浓缩,浓缩后的固体以二氯甲烷为溶剂,重结晶得到纯产品6,产率86%。该产品的核磁分析数据如下:1H NMR. (400 MHz, DMSO-d6): 7.11 (t, 1H), 6.99 (d, 1H), 6.74 (m, 2H), 6.64 (d, 1H), 6.29 (m, 2H), 5.95(s, 1H), 4.24 (s, 2H), 3.76 (s, 3H)。Preparation of diaryldiazepines (6): Under nitrogen protection, add 1.0mmol o-bromobenzyl alcohol, 1.2mmol 4-methoxy-1,2-o-phenylenediamine, 0.04mmol RuH 2 (PPh 3 ) 4 , 0.06mmol cuprous chloride, 3.0mmol ethylene glycol, 5.0mmol potassium tert-butoxide, and 5ml di Replace the reaction tube with nitrogen for 3 times with toluene, then heat to 120°C with an oil bath under magnetic stirring, and reflux the reaction for 24 hours. Remove the oil bath, and the water bath is lowered to room temperature; add 3ml of water to the reaction solution, extract three times with 5ml of ethyl acetate, combine the organic phases and use anhydrous MgSO Dry for 30 minutes, filter; the filtrate is concentrated with a rotary evaporator, and the concentrated solid Using dichloromethane as solvent, the pure product 6 was obtained by recrystallization with a yield of 86%. The nuclear magnetic analysis data of this product are as follows: 1 H NMR. (400 MHz, DMSO-d6): 7.11 (t, 1H), 6.99 (d, 1H), 6.74 (m, 2H), 6.64 (d, 1H), 6.29 (m, 2H), 5.95(s, 1H), 4.24 (s, 2H), 3.76 (s, 3H).

实施例4Example 4

二芳基并二氮杂卓类化合物(10)的制备:在氮气保护下,向10 ml的Schlek反应管(无水无氧操作时常用的一种玻璃仪器)加入1.0mmol邻碘苯甲醇、1.3mmol 4-氟-1,2-邻苯二胺、0.1mmol RuH2(PPh3)4、0.1mmol碘化亚铜、6.0mmol乙二醇、9.0mmol叔丁醇钠、和5ml二甲苯,用氮气置换反应管3次,然后在磁力搅拌下用油浴加热至120℃,反应回流36小时。去掉油浴,水浴降到室温;向反应液加3ml水,用5ml的乙酸乙酯萃取三次,合并有机相并用无水MgSO4干燥30分钟,过滤;滤液用旋转蒸发器浓缩,浓缩后的固体以二氯甲烷为溶剂,重结晶得到纯产品10,产率83%。该产品的核磁分析数据如下:1H NMR. (400 MHz, DMSO-d6): 7.14 (d, 1H), 7.02 (d, 1H), 6.78 (d, 1H), 6.74 (d, 1H), 6.60 (d, 2H), 6.47(d, 1H), 6.40 (d, 1H), 5.70(s, 1H), 4.32 (s, 2H), 4.09 (s, 1H)。Preparation of diaryldiazepines (10): under nitrogen protection, add 1.0mmol o-iodobenzyl alcohol, 1.3 mmol 4-fluoro-1,2-o-phenylenediamine, 0.1 mmol RuH 2 (PPh 3 ) 4 , 0.1 mmol cuprous iodide, 6.0 mmol ethylene glycol, 9.0 mmol sodium tert-butoxide, and 5 ml xylene, The reaction tube was replaced with nitrogen for 3 times, then heated to 120° C. in an oil bath under magnetic stirring, and the reaction was refluxed for 36 hours. Remove the oil bath, and the water bath is lowered to room temperature; add 3ml of water to the reaction solution, extract three times with 5ml of ethyl acetate, combine the organic phases and use anhydrous MgSO Dry for 30 minutes, filter; the filtrate is concentrated with a rotary evaporator, and the concentrated solid The pure product 10 was obtained by recrystallization with dichloromethane as solvent, and the yield was 83%. The nuclear magnetic analysis data of this product are as follows: 1 H NMR. (400 MHz, DMSO-d6): 7.14 (d, 1H), 7.02 (d, 1H), 6.78 (d, 1H), 6.74 (d, 1H), 6.60 (d, 2H), 6.47(d, 1H), 6.40 (d, 1H), 5.70 (s, 1H), 4.32 (s, 2H), 4.09 (s, 1H).

实施例5Example 5

二芳基并二氮杂卓类化合物(12)的制备:在氮气保护下,向10 ml的Schlek反应管(无水无氧操作时常用的一种玻璃仪器)加入1.0mmol 4-三氟甲基邻溴苯甲醇、1.5mmol 1,2-邻苯二胺、0.04mmol对伞花烃二氯化钌二聚体、0.08mmol碘化亚铜、5.0mmol乙二醇、5.0mmol氢氧化钠、和5ml苯,用氮气置换反应管3次,然后在磁力搅拌下用油浴加热至100℃,反应回流30小时。去掉油浴,水浴降到室温;向反应液加3ml水,用5ml的乙酸乙酯萃取三次,合并有机相并用无水MgSO4干燥30分钟,过滤;滤液用旋转蒸发器浓缩,浓缩后的固体以二氯甲烷为溶剂,重结晶得到纯产品12,产率87%。该产品的核磁分析数据如下:1H NMR.(400 MHz, DMSO-d6): 7.18 (t, 1H), 7.06 (d, 1H), 7.03 (d, 1H), 6.92 (s,1H), 6.84 (t, 1H), 6.78 (d, 1H), 6.75 (d, 1H), 6.10 (s, 1H), 4.33 (s, 2H)。Preparation of diaryldiazepines (12): under nitrogen protection, add 1.0mmol 4-trifluoroform to a 10 ml Schlek reaction tube (a glass instrument commonly used in anhydrous and oxygen-free operation) 1-bromobenzyl alcohol, 1.5mmol 1,2-o-phenylenediamine, 0.04mmol p-cymene dichloride ruthenium dimer, 0.08mmol cuprous iodide, 5.0mmol ethylene glycol, 5.0mmol sodium hydroxide, and 5ml of benzene, the reaction tube was replaced with nitrogen for 3 times, and then heated to 100° C. in an oil bath under magnetic stirring, and the reaction was refluxed for 30 hours. Remove the oil bath, and the water bath is lowered to room temperature; add 3ml of water to the reaction solution, extract three times with 5ml of ethyl acetate, combine the organic phases and use anhydrous MgSO Dry for 30 minutes, filter; the filtrate is concentrated with a rotary evaporator, and the concentrated solid The pure product 12 was obtained by recrystallization with dichloromethane as solvent, and the yield was 87%. The nuclear magnetic analysis data of this product are as follows: 1 H NMR.(400 MHz, DMSO-d6): 7.18 (t, 1H), 7.06 (d, 1H), 7.03 (d, 1H), 6.92 (s, 1H), 6.84 (t, 1H), 6.78 (d, 1H), 6.75 (d, 1H), 6.10 (s, 1H), 4.33 (s, 2H).

实施例6Example 6

二芳基并二氮杂卓类化合物(15)的制备:在氮气保护下,向10 ml的Schlek反应管(无水无氧操作时常用的一种玻璃仪器)加入1.0mmol邻碘苯甲醇、1.4mmol 4-氰基-1,2-邻苯二胺、0.03mmol Ru(PPh3)2Cl2、0.09mmol碘化亚铜、6.0mmol乙二醇、5.0mmol叔丁醇钠、和5ml二甲苯,用氮气置换反应管3次,然后在磁力搅拌下用油浴加热至120℃,反应回流24小时。去掉油浴,水浴降到室温;向反应液加3ml水,用5ml的乙酸乙酯萃取三次,合并有机相并用无水MgSO4干燥30分钟,过滤;滤液用旋转蒸发器浓缩,浓缩后的固体以二氯甲烷为溶剂,重结晶得到纯产品15,产率80%。该产品的核磁分析数据如下:1H NMR. (400 MHz, DMSO-d6): 7.19 (t, 1H), 7.06 (m, 2H), 6.92 (d, 1H), 6.86 (t, 1H), 6.80 (d, 1H),6.70 (d, 1H), 6.18 (s, 1H), 4.31 (s, 2H)。Preparation of diaryldiazepines (15): under nitrogen protection, add 1.0mmol o-iodobenzyl alcohol, 1.4mmol 4-cyano-1,2-o-phenylenediamine, 0.03mmol Ru(PPh 3 ) 2 Cl 2 , 0.09mmol cuprous iodide, 6.0mmol ethylene glycol, 5.0mmol sodium tert-butoxide, and 5ml di Replace the reaction tube with nitrogen for 3 times with toluene, then heat to 120°C with an oil bath under magnetic stirring, and reflux the reaction for 24 hours. Remove the oil bath, and the water bath is lowered to room temperature; add 3ml of water to the reaction solution, extract three times with 5ml of ethyl acetate, combine the organic phases and use anhydrous MgSO Dry for 30 minutes, filter; the filtrate is concentrated with a rotary evaporator, and the concentrated solid The pure product 15 was obtained by recrystallization with dichloromethane as solvent, and the yield was 80%. The nuclear magnetic analysis data of this product are as follows: 1 H NMR. (400 MHz, DMSO-d6): 7.19 (t, 1H), 7.06 (m, 2H), 6.92 (d, 1H), 6.86 (t, 1H), 6.80 (d, 1H), 6.70 (d, 1H), 6.18 (s, 1H), 4.31 (s, 2H).

实施例7Example 7

二芳基并二氮杂卓类化合物(17)的制备:在氮气保护下,向10 ml的Schlek反应管(无水无氧操作时常用的一种玻璃仪器)加入1.0mmol邻溴苯甲醇、1.2mmol 4-甲酸甲酯基-1,2-邻苯二胺、0.06mmol RuH2(PPh3)4、0.07mmol碘化亚铜、5.0mmol乙二醇、6.0mmol叔丁醇钾、和5ml甲苯,用氮气置换反应管3次,然后在磁力搅拌下用油浴加热至100℃,反应回流30小时。去掉油浴,水浴降到室温;向反应液加3ml水,用5ml的乙酸乙酯萃取三次,合并有机相并用无水MgSO4干燥30分钟,过滤;滤液用旋转蒸发器浓缩,浓缩后的固体以二氯甲烷为溶剂,重结晶得到纯产品17,产率78%。该产品的核磁分析数据如下:1H NMR. (400 MHz,DMSO-d6): 7.49 (d, 1H), 7.39 (d, 1H), 7.16 (d, 1H), 7.04 (t, 1H), 6.77-6.84 (m, 2H), 6.70 (d, 1H), 6.26 (s, 1H), 4.29 (s, 2H), 3.88 (s, 3H)。Preparation of diaryldiazepines (17): under nitrogen protection, add 1.0mmol o-bromobenzyl alcohol, 1.2mmol 4-methylcarboxy-1,2-o-phenylenediamine, 0.06mmol RuH 2 (PPh 3 ) 4 , 0.07mmol cuprous iodide, 5.0mmol ethylene glycol, 6.0mmol potassium tert-butoxide, and 5ml Replace the reaction tube with nitrogen for 3 times with toluene, then heat to 100°C with an oil bath under magnetic stirring, and reflux for 30 hours. Remove the oil bath, and the water bath is lowered to room temperature; add 3ml of water to the reaction solution, extract three times with 5ml of ethyl acetate, combine the organic phases and use anhydrous MgSO Dry for 30 minutes, filter; the filtrate is concentrated with a rotary evaporator, and the concentrated solid The pure product 17 was obtained by recrystallization with dichloromethane as solvent, and the yield was 78%. The nuclear magnetic analysis data of this product are as follows: 1 H NMR. (400 MHz,DMSO-d6): 7.49 (d, 1H), 7.39 (d, 1H), 7.16 (d, 1H), 7.04 (t, 1H), 6.77-6.84 (m, 2H), 6.70 (d, 1H), 6.26 (s, 1H) , 4.29 (s, 2H), 3.88 (s, 3H).

实施例8Example 8

二芳基并二氮杂卓类化合物(20)的制备:在氮气保护下,向10 ml的Schlek反应管(无水无氧操作时常用的一种玻璃仪器)加入1.0mmol 5-甲基邻碘苯甲醇、1.3mmol 4-甲氧基-1,2-邻苯二胺、0.06mmol 对伞花烃二氯化钌二聚体、0.08mmol氯化亚铜、4.0mmol乙二醇、4.0mmol氢氧化钾、和5ml二氧六环,用氮气置换反应管3次,然后在磁力搅拌下用油浴加热至110℃,反应回流18小时。去掉油浴,水浴降到室温;向反应液加3ml水,用5ml的乙酸乙酯萃取三次,合并有机相并用无水MgSO4干燥30分钟,过滤;滤液用旋转蒸发器浓缩,浓缩后的固体以二氯甲烷为溶剂,重结晶得到纯产品20,产率85%。该产品的核磁分析数据如下:1HNMR. (400 MHz, DMSO-d6): 7.09 (d, 1H), 6.97 (d, 1H), 6.76 (d, 1H), 6.63(d, 1H), 6.26 (s, 1H), 5.93 (s, 1H), 5.88 (s, 1H), 4.23 (s, 2H), 3.75 (s,3H), 2.23 (s, 3H)。Preparation of diaryldiazepines (20): Under nitrogen protection, add 1.0 mmol of 5-methyl-ortho Iodobenzyl alcohol, 1.3mmol 4-methoxy-1,2-o-phenylenediamine, 0.06mmol p-cymene dichloride ruthenium dimer, 0.08mmol cuprous chloride, 4.0mmol ethylene glycol, 4.0mmol Potassium hydroxide, and 5ml of dioxane, the reaction tube was replaced with nitrogen for 3 times, then heated to 110° C. in an oil bath under magnetic stirring, and the reaction was refluxed for 18 hours. Remove the oil bath, and the water bath is lowered to room temperature; add 3ml of water to the reaction solution, extract three times with 5ml of ethyl acetate, combine the organic phases and use anhydrous MgSO Dry for 30 minutes, filter; the filtrate is concentrated with a rotary evaporator, and the concentrated solid Using dichloromethane as a solvent, the pure product 20 was obtained by recrystallization with a yield of 85%. The nuclear magnetic analysis data of this product are as follows: 1 HNMR. (400 MHz, DMSO-d6): 7.09 (d, 1H), 6.97 (d, 1H), 6.76 (d, 1H), 6.63(d, 1H), 6.26 (s, 1H), 5.93 (s, 1H), 5.88 (s, 1H), 4.23 (s, 2H), 3.75 (s, 3H), 2.23 (s, 3H).

实施例9Example 9

二芳基并二氮杂卓类化合物(22)的制备:在氮气保护下,向10 ml的Schlek反应管(无水无氧操作时常用的一种玻璃仪器)加入1.0mmol 5-氰基邻溴苯甲醇、1.2mmol 4-甲基-1,2-邻苯二胺、0.05mmol RuH2(PPh3)4、0.06mmol碘化亚铜、3.0mmol乙二醇、5.0mmol氢氧化钠、和5ml甲苯,用氮气置换反应管3次,然后在磁力搅拌下用油浴加热至100℃,反应回流24小时。去掉油浴,水浴降到室温;向反应液加3ml水,用5ml的乙酸乙酯萃取三次,合并有机相并用无水MgSO4干燥30分钟,过滤;滤液用旋转蒸发器浓缩,浓缩后的固体以二氯甲烷为溶剂,重结晶得到纯产品22,产率87%。该产品的核磁分析数据如下:1H NMR. (400 MHz,DMSO-d6): 7.18 (d, 1H), 7.05 (d, 1H), 6.87 (d, 1H), 6.76 (d, 1H), 6.35 (s,1H), 6.07 (s, 1H), 5.93 (s, 1H), 4.25 (s, 2H), 2.22 (s, 3H)。Preparation of diaryldiazepines (22): under nitrogen protection, add 1.0mmol 5-cyano-ortho Bromobenzyl alcohol, 1.2 mmol 4-methyl-1,2-o-phenylenediamine, 0.05 mmol RuH 2 (PPh 3 ) 4 , 0.06 mmol cuprous iodide, 3.0 mmol ethylene glycol, 5.0 mmol sodium hydroxide, and 5ml of toluene was used to replace the reaction tube with nitrogen for 3 times, and then heated to 100°C with an oil bath under magnetic stirring, and the reaction was refluxed for 24 hours. Remove the oil bath, and the water bath is lowered to room temperature; add 3ml of water to the reaction solution, extract three times with 5ml of ethyl acetate, combine the organic phases and use anhydrous MgSO Dry for 30 minutes, filter; the filtrate is concentrated with a rotary evaporator, and the concentrated solid The pure product 22 was obtained by recrystallization with dichloromethane as solvent, and the yield was 87%. The nuclear magnetic analysis data of this product are as follows: 1 H NMR. (400 MHz,DMSO-d6): 7.18 (d, 1H), 7.05 (d, 1H), 6.87 (d, 1H), 6.76 (d, 1H), 6.35 (s, 1H), 6.07 (s, 1H), 5.93 (s, 1H), 4.25 (s, 2H), 2.22 (s, 3H).

实施例10Example 10

二芳基并二氮杂卓类化合物(24)的制备:在氮气保护下,向10 ml的Schlek反应管(无水无氧操作时常用的一种玻璃仪器)加入1.0mmol 4-甲氧基邻碘苯甲醇、1.4mmol 3-甲基-1,2-邻苯二胺、0.07mmol Ru(PPh3)2Cl2、0.05mmol碘化亚铜、3.0mmol乙二醇、3.0mmol叔丁醇钠、和5ml苯,用氮气置换反应管3次,然后在磁力搅拌下用油浴加热至90℃,反应回流22小时。去掉油浴,水浴降到室温;向反应液加3ml水,用5ml的乙酸乙酯萃取三次,合并有机相并用无水MgSO4干燥30分钟,过滤;滤液用旋转蒸发器浓缩,浓缩后的固体以二氯甲烷为溶剂,重结晶得到纯产品24,产率81%。该产品的核磁分析数据如下:1H NMR. (400 MHz,DMSO-d6): 7.11 (d, 1H), 7.02 (d, 1H), 6.68-6.75 (m, 2H), 6.46-6.55 (m,2H), 5.86 (s, 1H), 5.82 (s, 1H), 4.24 (s, 2H), 3.73 (s, 3H), 2.23 (s, 3H)。Preparation of diaryldiazepines (24): under nitrogen protection, add 1.0mmol 4-methoxy o-iodobenzyl alcohol, 1.4mmol 3-methyl-1,2-o-phenylenediamine, 0.07mmol Ru(PPh 3 ) 2 Cl 2 , 0.05mmol cuprous iodide, 3.0mmol ethylene glycol, 3.0mmol tert-butanol Sodium, and 5ml of benzene, the reaction tube was replaced with nitrogen for 3 times, and then heated to 90°C with an oil bath under magnetic stirring, and the reaction was refluxed for 22 hours. Remove the oil bath, and the water bath is lowered to room temperature; add 3ml of water to the reaction solution, extract three times with 5ml of ethyl acetate, combine the organic phases and use anhydrous MgSO Dry for 30 minutes, filter; the filtrate is concentrated with a rotary evaporator, and the concentrated solid The pure product 24 was obtained by recrystallization with dichloromethane as solvent, and the yield was 81%. The nuclear magnetic analysis data of this product are as follows: 1 H NMR. (400 MHz,DMSO-d6): 7.11 (d, 1H), 7.02 (d, 1H), 6.68-6.75 (m, 2H), 6.46-6.55 (m, 2H), 5.86 (s, 1H), 5.82 (s, 1H), 4.24 (s, 2H), 3.73 (s, 3H), 2.23 (s, 3H).

实施例11Example 11

二芳基并二氮杂卓类化合物(27)的制备:在氮气保护下,向10 ml的Schlek反应管(无水无氧操作时常用的一种玻璃仪器)加入1.0mmol邻碘苯甲醇、1.3mmol 1,2-邻苯N-甲基二胺、0.06mmol Ru(PPh3)2Cl2、0.09mmol氯化亚铜、5.0mmol乙二醇、3.0mmol叔丁醇钾、和5ml二甲苯,用氮气置换反应管3次,然后在磁力搅拌下用油浴加热至120℃,反应回流30小时。去掉油浴,水浴降到室温;向反应液加3ml水,用5ml的乙酸乙酯萃取三次,合并有机相并用无水MgSO4干燥30分钟,过滤;滤液用旋转蒸发器浓缩,浓缩后的固体以二氯甲烷为溶剂,重结晶得到纯产品27,产率79%。该产品的核磁分析数据如下:1H NMR. (400 MHz, DMSO-d6): 7.22 (d, 1H), 7.15 (d, 1H),7.08 (m, 2H), 6.96 (d, 1H), 6.90 (d, 1H), 6.75-6.82 (m, 3H), 4.29 (s, 2H), 3.22 (s, 3H), 2.81 (s, 3H)。Preparation of diaryldiazepines (27): Under nitrogen protection, add 1.0 mmol o-iodobenzyl alcohol, 1.3 mmol 1,2-o-phenylene N-methyldiamine, 0.06 mmol Ru(PPh 3 ) 2 Cl 2 , 0.09 mmol cuprous chloride, 5.0 mmol ethylene glycol, 3.0 mmol potassium tert-butoxide, and 5 ml xylene , the reaction tube was replaced with nitrogen for 3 times, and then heated to 120° C. in an oil bath under magnetic stirring, and the reaction was refluxed for 30 hours. Remove the oil bath, and the water bath is lowered to room temperature; add 3ml of water to the reaction solution, extract three times with 5ml of ethyl acetate, combine the organic phases and use anhydrous MgSO Dry for 30 minutes, filter; the filtrate is concentrated with a rotary evaporator, and the concentrated solid Using dichloromethane as solvent, the pure product 27 was obtained by recrystallization with a yield of 79%. The nuclear magnetic analysis data of this product are as follows: 1 H NMR. (400 MHz, DMSO-d6): 7.22 (d, 1H), 7.15 (d, 1H), 7.08 (m, 2H), 6.96 (d, 1H), 6.90 (d, 1H), 6.75-6.82 (m, 3H), 4.29 (s, 2H) , 3.22 (s, 3H), 2.81 (s, 3H).

实施例12Example 12

二芳基并二氮杂卓类化合物(28)的制备:在氮气保护下,向10 ml的Schlek反应管(无水无氧操作时常用的一种玻璃仪器)加入1.0mmol邻碘苯甲醇、1.5mmol 4-甲氧基-1,2-邻苯N-甲基二胺、0.07mmol对伞花烃二氯化钌二聚体、0.1mmol碘化亚铜、6.0mmol乙二醇、6.0mmol氢氧化钾、和5ml二氧六环,用氮气置换反应管3次,然后在磁力搅拌下用油浴加热至120℃,反应回流30小时。去掉油浴,水浴降到室温;向反应液加3ml水,用5ml的乙酸乙酯萃取三次,合并有机相并用无水MgSO4干燥30分钟,过滤;滤液用旋转蒸发器浓缩,浓缩后的固体以二氯甲烷为溶剂,重结晶得到纯产品28,产率81%。该产品的核磁分析数据如下:1HNMR. (400 MHz, DMSO-d6): 7.10 (t, 1H), 6.97 (d, 1H), 6.72 (m, 2H), 6.61(d, 1H), 6.25 (m, 2H), 5.93 (s, 1H), 4.26 (s, 2H), 3.23 (s, 3H), 2.80 (s,3H)。Preparation of diaryldiazepines (28): Under nitrogen protection, add 1.0 mmol o-iodobenzyl alcohol, 1.5mmol 4-methoxy-1,2-o-phenylene N-methyldiamine, 0.07mmol p-cymene dichloride ruthenium dimer, 0.1mmol cuprous iodide, 6.0mmol ethylene glycol, 6.0mmol Potassium hydroxide, and 5ml of dioxane, the reaction tube was replaced with nitrogen for 3 times, then heated to 120°C with an oil bath under magnetic stirring, and the reaction was refluxed for 30 hours. Remove the oil bath, and the water bath is lowered to room temperature; add 3ml of water to the reaction solution, extract three times with 5ml of ethyl acetate, combine the organic phases and use anhydrous MgSO Dry for 30 minutes, filter; the filtrate is concentrated with a rotary evaporator, and the concentrated solid Using dichloromethane as solvent, the pure product 28 was obtained by recrystallization with a yield of 81%. The nuclear magnetic analysis data of this product are as follows: 1 HNMR. (400 MHz, DMSO-d6): 7.10 (t, 1H), 6.97 (d, 1H), 6.72 (m, 2H), 6.61(d, 1H), 6.25 (m, 2H), 5.93 (s, 1H), 4.26 (s, 2H), 3.23 (s, 3H), 2.80 (s, 3H).

实施例13Example 13

二芳基并二氮杂卓类化合物(30)的制备:在氮气保护下,向10 ml的Schlek反应管(无水无氧操作时常用的一种玻璃仪器)加入1.0mmol邻碘苯甲醇、1.4mmol 4-氰基-1,2-邻苯N-甲基二胺、0.06mmol RuH2(PPh3)4、0.08mmol氯化亚铜、5.0mmol乙二醇、5.0mmol叔丁醇钾、和5ml甲苯,用氮气置换反应管3次,然后在磁力搅拌下用油浴加热至100℃,反应回流38小时。去掉油浴,水浴降到室温;向反应液加3ml水,用5ml的乙酸乙酯萃取三次,合并有机相并用无水MgSO4干燥30分钟,过滤;滤液用旋转蒸发器浓缩,浓缩后的固体以二氯甲烷为溶剂,重结晶得到纯产品30,产率75%。该产品的核磁分析数据如下:1H NMR. (400 MHz,DMSO-d6): 7.16 (t, 1H), 7.05 (d, 2H), 6.89 (d, 1H), 6.84 (d, 1H), 6.76 (d,1H), 6.66 (d, 1H), 6.13 (s, 1H), 4.30 (s, 2H), 3.25 (s, 3H), 2.81 (s, 3H)。Preparation of diaryldiazepines (30): under nitrogen protection, add 1.0 mmol o-iodobenzyl alcohol, 1.4mmol 4-cyano-1,2-o-phenylene N-methyldiamine, 0.06mmol RuH 2 (PPh 3 ) 4 , 0.08mmol cuprous chloride, 5.0mmol ethylene glycol, 5.0mmol potassium tert-butoxide, and 5ml of toluene, the reaction tube was replaced with nitrogen for 3 times, and then heated to 100° C. in an oil bath under magnetic stirring, and the reaction was refluxed for 38 hours. Remove the oil bath, and the water bath is lowered to room temperature; add 3ml of water to the reaction solution, extract three times with 5ml of ethyl acetate, combine the organic phases and use anhydrous MgSO Dry for 30 minutes, filter; the filtrate is concentrated with a rotary evaporator, and the concentrated solid Using dichloromethane as solvent, the pure product 30 was obtained by recrystallization with a yield of 75%. The nuclear magnetic analysis data of this product are as follows: 1 H NMR. (400 MHz,DMSO-d6): 7.16 (t, 1H), 7.05 (d, 2H), 6.89 (d, 1H), 6.84 (d, 1H), 6.76 (d,1H), 6.66 (d, 1H), 6.13 (s, 1H), 4.30 (s, 2H), 3.25 (s, 3H), 2.81 (s, 3H).

实施例14Example 14

二芳基并二氮杂卓类化合物(32)的制备:在氮气保护下,向10 ml的Schlek反应管(无水无氧操作时常用的一种玻璃仪器)加入1.0mmol邻溴苯甲醇、1.5mmol 3-三氟甲基-1,2-邻苯N-甲基二胺、0.08mmol对伞花烃二氯化钌二聚体、0.1mmol碘化亚铜、6.0mmol乙二醇、9.0mmol氢氧化钾、和5ml二甲苯,用氮气置换反应管3次,然后在磁力搅拌下用油浴加热至120℃,反应回流40小时。去掉油浴,水浴降到室温;向反应液加3ml水,用5ml的乙酸乙酯萃取三次,合并有机相并用无水MgSO4干燥30分钟,过滤;滤液用旋转蒸发器浓缩,浓缩后的固体以二氯甲烷为溶剂,重结晶得到纯产品32,产率75%。该产品的核磁分析数据如下:1HNMR. (400 MHz, DMSO-d6): 7.15 (t, 1H), 7.03 (d, 1H), 7.01 (s, 1H), 6.90(s, 1H), 6.81 (t, 1H), 6.75 (d, 1H), 6.70 (s, 1H), 6.05 (s, 1H), 4.25 (s,2H), 3.24 (s, 3H), 2.81 (s, 3H)。Preparation of diaryldiazepines (32): under nitrogen protection, add 1.0 mmol o-bromobenzyl alcohol, 1.5mmol 3-trifluoromethyl-1,2-o-phenylene N-methyldiamine, 0.08mmol p-cymene dichloride ruthenium dimer, 0.1mmol cuprous iodide, 6.0mmol ethylene glycol, 9.0 Mmol potassium hydroxide and 5ml xylene were used to replace the reaction tube with nitrogen for 3 times, then heated to 120° C. in an oil bath under magnetic stirring, and the reaction was refluxed for 40 hours. Remove the oil bath, and the water bath is lowered to room temperature; add 3ml of water to the reaction solution, extract three times with 5ml of ethyl acetate, combine the organic phases and use anhydrous MgSO Dry for 30 minutes, filter; the filtrate is concentrated with a rotary evaporator, and the concentrated solid The pure product 32 was obtained by recrystallization with dichloromethane as solvent, and the yield was 75%. The nuclear magnetic analysis data of this product are as follows: 1 HNMR. (400 MHz, DMSO-d6): 7.15 (t, 1H), 7.03 (d, 1H), 7.01 (s, 1H), 6.90(s, 1H), 6.81 (t, 1H), 6.75 (d, 1H), 6.70 (s, 1H), 6.05 (s, 1H), 4.25 (s, 2H), 3.24 (s, 3H), 2.81 (s, 3H).

实施例15Example 15

二芳基并二氮杂卓类化合物(34)的制备:在氮气保护下,向10 ml的Schlek反应管(无水无氧操作时常用的一种玻璃仪器)加入1.0mmol 5-甲氧基邻碘苯甲醇、1.3mmol 4-甲基-1,2-邻苯N-甲基二胺、0.08mmol RuH2(PPh3)4、0.08mmol氯化亚铜、5.0mmol乙二醇、5.0mmol叔丁醇钠、和5ml二氧六环,用氮气置换反应管3次,然后在磁力搅拌下用油浴加热至110℃,反应回流36小时。去掉油浴,水浴降到室温;向反应液加3ml水,用5ml的乙酸乙酯萃取三次,合并有机相并用无水MgSO4干燥30分钟,过滤;滤液用旋转蒸发器浓缩,浓缩后的固体以二氯甲烷为溶剂,重结晶得到纯产品34,产率77%。该产品的核磁分析数据如下:1H NMR. (400MHz, DMSO-d6): 7.08 (d, 1H), 6.96 (d, 1H), 6.78 (d, 1H), 6.62 (d, 1H),6.25 (s, 1H), 5.92 (s, 1H), 5.85 (s, 1H), 4.26 (s, 2H), 3.76 (s, 3H), 3.23(s, 3H), 2.80 (s, 3H), 2.23 (s, 3H)。Preparation of diaryldiazepines (34): under nitrogen protection, add 1.0mmol 5-methoxy o-iodobenzyl alcohol, 1.3mmol 4-methyl-1,2-o-phenylene N-methyldiamine, 0.08mmol RuH 2 (PPh 3 ) 4 , 0.08mmol cuprous chloride, 5.0mmol ethylene glycol, 5.0mmol Sodium tert-butoxide, and 5ml of dioxane, the reaction tube was replaced with nitrogen for 3 times, then heated to 110° C. in an oil bath under magnetic stirring, and the reaction was refluxed for 36 hours. Remove the oil bath, and the water bath is lowered to room temperature; add 3ml of water to the reaction solution, extract three times with 5ml of ethyl acetate, combine the organic phases and use anhydrous MgSO Dry for 30 minutes, filter; the filtrate is concentrated with a rotary evaporator, and the concentrated solid Using dichloromethane as solvent, the pure product 34 was obtained by recrystallization with a yield of 77%. The nuclear magnetic analysis data of this product are as follows: 1 H NMR. (400MHz, DMSO-d6): 7.08 (d, 1H), 6.96 (d, 1H), 6.78 (d, 1H), 6.62 (d, 1H), 6.25 (s, 1H), 5.92 (s, 1H), 5.85 (s, 1H), 4.26 (s, 2H), 3.76 (s, 3H), 3.23(s, 3H), 2.80 (s, 3H), 2.23 (s, 3H).

实施例16Example 16

二芳基并二氮杂卓类化合物(36)的制备:在氮气保护下,向10 ml的Schlek反应管(无水无氧操作时常用的一种玻璃仪器)加入1.0mmol 5-氰基邻溴苯甲醇、1.3mmol 4-甲基1,2-邻苯N-甲基二胺、0.05mmol对伞花烃二氯化钌二聚体、0.1mmol碘化亚铜、6.0mmol乙二醇、6.0mmol叔丁醇钾、和5ml二甲苯,用氮气置换反应管3次,然后在磁力搅拌下用油浴加热至120℃,反应回流38小时。去掉油浴,水浴降到室温;向反应液加3ml水,用5ml的乙酸乙酯萃取三次,合并有机相并用无水MgSO4干燥30分钟,过滤;滤液用旋转蒸发器浓缩,浓缩后的固体以二氯甲烷为溶剂,重结晶得到纯产品36,产率82%。该产品的核磁分析数据如下:1HNMR. (400 MHz, DMSO-d6): 7.19 (d, 1H), 7.08 (d, 1H), 6.89 (d, 1H), 6.77 (d,1H), 6.38 (s, 1H), 6.09 (s, 1H), 5.96 (s, 1H), 4.29 (s, 2H), 3.25 (s, 3H),2.82 (s, 3H), 2.25 (s, 3H)。Preparation of diaryldiazepines (36): under nitrogen protection, add 1.0mmol 5-cyano-ortho Bromobenzyl alcohol, 1.3mmol 4-methyl 1,2-o-phenylene N-methyldiamine, 0.05mmol p-cymene dichloride ruthenium dimer, 0.1mmol cuprous iodide, 6.0mmol ethylene glycol, 6.0 mmol of potassium tert-butoxide and 5 ml of xylene were used to replace the reaction tube with nitrogen three times, then heated to 120° C. in an oil bath under magnetic stirring, and the reaction was refluxed for 38 hours. Remove the oil bath, and the water bath is lowered to room temperature; add 3ml of water to the reaction solution, extract three times with 5ml of ethyl acetate, combine the organic phases and use anhydrous MgSO Dry for 30 minutes, filter; the filtrate is concentrated with a rotary evaporator, and the concentrated solid The pure product 36 was obtained by recrystallization with dichloromethane as solvent, and the yield was 82%. The nuclear magnetic analysis data of this product are as follows: 1 HNMR. (400 MHz, DMSO-d6): 7.19 (d, 1H), 7.08 (d, 1H), 6.89 (d, 1H), 6.77 (d, 1H), 6.38 (s, 1H), 6.09 (s, 1H), 5.96 (s, 1H), 4.29 (s, 2H), 3.25 (s, 3H), 2.82 (s, 3H), 2.25 (s, 3H).

Claims (7)

1. the synthetic method of diaryl Diazepines, it is characterised in that: take adjacent halogenated aryl methyl alcohol, 1,2-diamines Aromatic hydrocarbons, ruthenium catalyst, mantoquita, ethylene glycol and alkali join in organic solvent, at N2The lower heating of protection, reaction terminate after extraction, It is evaporated, recrystallize and i.e. obtain product;
The structural formula of described adjacent halogenated aryl methyl alcohol is as follows:
The structural formula of described 1,2-diamines aromatic hydrocarbons is as follows:
Wherein: R is-H ,-CH3、-OCH3,-F or-CF3, R is positioned at any position on aromatic ring 1-4;X is-Br or-I; R1Can be- H or-CH3;R2For-H ,-CH3、-OCH3,-COOMe ,-CN ,-F or-CF3, R2It is positioned at any position on aromatic ring 5-8;
The structural formula of described diaryl Diazepines is as follows:
R, R in this diaryl Diazepines1And R2Group and adjacent halogenated aryl methyl alcohol, 1,2-diamines aromatic hydrocarbons R、R1And R2Group connotation is identical.
2. the synthetic method of diaryl as claimed in claim 1 Diazepines, it is characterised in that: described adjacent halogen For aryl methyl alcohol, 1,2-diamines aromatic hydrocarbons, the mol ratio of ruthenium catalyst, mantoquita, ethylene glycol and alkali is 1:1~1.5:0.03~0.1: 0.05~0.1:2~6:3~9.
3. the synthetic method of diaryl as claimed in claim 1 Diazepines, it is characterised in that: described heating The condition of reaction is: reaction temperature is 80-120 DEG C, reaction time 6-48h, and product is carried after terminating by reaction by recrystallization Pure.
4. the synthetic method of the diaryl as described in any claim in claim 1-3 Diazepines, its It is characterised by: described ruthenium catalyst is p-cymene ruthenous chloride dimer, RuH2(PPh3)4Or Ru (PPh3)2Cl2
5. the synthetic method of the diaryl as described in any claim in claim 1-3 Diazepines, its It is characterised by: described mantoquita is cuprous iodide or stannous chloride.
6. the synthetic method of the diaryl as described in any claim in claim 1-3 Diazepines, its It is characterised by: described alkali is NaOH, potassium hydroxide, sodium tert-butoxide or potassium tert-butoxide.
7. the synthetic method of the diaryl as described in any claim in claim 1-3 Diazepines, its It is characterised by: described organic solvent is benzene,toluene,xylene or dioxane.
CN201610381171.2A 2016-06-01 2016-06-01 The synthetic method of diaryl and Diazepines Expired - Fee Related CN106083728B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610381171.2A CN106083728B (en) 2016-06-01 2016-06-01 The synthetic method of diaryl and Diazepines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610381171.2A CN106083728B (en) 2016-06-01 2016-06-01 The synthetic method of diaryl and Diazepines

Publications (2)

Publication Number Publication Date
CN106083728A true CN106083728A (en) 2016-11-09
CN106083728B CN106083728B (en) 2018-06-05

Family

ID=57229892

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610381171.2A Expired - Fee Related CN106083728B (en) 2016-06-01 2016-06-01 The synthetic method of diaryl and Diazepines

Country Status (1)

Country Link
CN (1) CN106083728B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1106802A (en) * 1993-07-29 1995-08-16 美国氰胺公司 Tricyclic benzazepines (aza *) vasopressin antagonists
US5869483A (en) * 1993-07-29 1999-02-09 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1106802A (en) * 1993-07-29 1995-08-16 美国氰胺公司 Tricyclic benzazepines (aza *) vasopressin antagonists
US5869483A (en) * 1993-07-29 1999-02-09 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
HIDETSURA CHO, ET AL.: "Synthesis of a Human Urate Transporter-1 Inhibitor, an Arginine Vasopressin Antagonist, and a 17β-Hydroxysteroid Dehydrogenase Type-3 Inhibitor, Using Ring-Expansion of Cyclic Ketoximes with DIBALH", 《CHEM. PHARM. BULL.》 *
JAYNE L. KENWRIGHT, ET AL.: "Novel and Efficient Copper-Catalysed Synthesis of Nitrogen-Linked Medium-Ring Biaryls", 《CHEM. EUR. J.》 *
JOYDEV K. LAHA, ET AL.: "Mechanistic Insights into the Palladium-Catalyzed Domino Synthesis of 10,11-Dihydro-5 H-dibenzo[b,e][1,4]diazepines", 《EUR. J. ORG. CHEM.》 *
JOYDEV K. LAHA, ET AL.: "Transition-Metal-Free Tandem Oxidative Removal of Benzylic Methylene Group by C − C and C − N Bond Cleavage Followed by Intramolecular New Aryl C − N Bond Formation under Radical Conditions", 《ORGANIC LETTERS》 *
徐兰婷.: "铜催化的交叉偶联反应在杂环化合物合成中的应用研究", 《中国博士学位论文全文数据库·工程科技I辑》 *

Also Published As

Publication number Publication date
CN106083728B (en) 2018-06-05

Similar Documents

Publication Publication Date Title
CN104744348B (en) Polysubstituted pyridine derivative and preparation method thereof
CN104926811B (en) The synthetic method of 3-cyanoimidazole also [1,2-a] pyridine compounds and application thereof
CN103772297B (en) Chirality six-membered heterocycle carbene precursor compound and its preparation method and application
CN109705013B (en) A kind of 1-(4-methylbenzyl)-3-amino-4-methylselenomaleimide compound and preparation method thereof
CN109651225B (en) Preparation method of 1-methyl-3-morphinyl-4-arylmercapto maleimide compound
CN107382803A (en) A kind of preparation method of β hydroxy phenyls selenide compound
CN111978236A (en) Preparation method of N-substituted-3-morpholinyl-4-phenylseleno maleimide compound
CN104447686B (en) Polysubstituted 2-pyrroles's pyridine derivate and preparation method thereof
CN103304393B (en) A kind of synthetic method of benzil analog derivative
CN105085208B (en) A kind of preparation method using palladium as catalyst benzfluorene ketone compounds
CN112028809A (en) Preparation method of 3-amino-4-phenylseleno maleimide compound
CN106117216A (en) A kind of method of atmospheric high efficiency synthesis 6H iso-indoles [2,1 a] indole 6 ketone compounds
CN104016917B (en) 5,6-dihydro coffee pyridine compounds and preparation method thereof
CN110357805B (en) Preparation method of N-methyl-3-phenylseleno maleimide compound
CN106083728B (en) The synthetic method of diaryl and Diazepines
CN111978237A (en) Preparation method of 3-morpholinyl-4-arylseleno maleimide compound
CN104230689B (en) 6,7-dihydro-5H-hexichol [a, c] ring heptan-5-ketone compounds and preparation method thereof
CN103012502B (en) Heteronuclear iridium gold bicyclo metal compound as well as preparation method and application of compound
CN103145769B (en) Bis-cyclometallated compound of heteronuclear ruthenium palladium and its preparation method and application
CN104876929A (en) Synthesis method and application of 1,2,3,4-tetrahydronaphthyridine compound
CN105198883A (en) Synthesis method of 11H-indolo [3,2-c] quinoline compounds
CN104774202A (en) Synthesis method of 9H-pyridino[2,3-b]indole compounds
CN105949143B (en) The synthetic method of diaryl and oxygen azatropylidene ketone compounds
CN101235037B (en) Method for synthesizing alkoxyporphyrin
CN103242379B (en) 2-ferrocenyl-aryl quinoline and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20180605

Termination date: 20190601